0.5555  0.001 (0.23%)		07-18 15:59
Open: 0.5743 High: 0.5743 Volume: 112,236		Pre. Close: 0.5542 Low: 0.535 Market Cap: 6(M)

Short term
Mid term
Targets	6-month :	0.72	1-year :	0.8
Resists	First :	0.61	Second :	0.69
Pivot price	0.58
Supports	First :	0.5	Second :	0.41
MAs	MA(5) :	0.55	MA(20) :	0.58
	MA(100) :	0.94	MA(250) :	1.39
MACD	MACD :	-0.1	Signal :	-0.1
%K %D	K(14,3) :	22.9	D(3) :	22.9
RSI	RSI(14): 44.9
52-week	High :	2.9	Low :	0.46

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ SRXH ] has closed above bottom band by 30.5%. Bollinger Bands are 62.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 34 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	0.57 - 0.58	0.58 - 0.58
Low:	0.53 - 0.53	0.53 - 0.53
Close:	0.55 - 0.55	0.55 - 0.56

SRx Health Solutions Inc. is an integrated Canadian healthcare services provider operating within the specialty healthcare industry. The company offers comprehensive, integrated, and customized specialty healthcare services across all ten Canadian provinces. SRx combines industry knowledge, technology, and a patient-centric focus to create strategies and solutions aimed at improving the wellness of Canadians.

Tue, 15 Jul 2025
SRx Health Solutions appoints Kent Cunningham as CEO - MarketScreener

Tue, 15 Jul 2025
SRx Health Solutions names Kent Cunningham as new CEO By Investing.com - Investing.com Nigeria

Tue, 15 Jul 2025
SRx Health Solutions Announces Management and Board Changes - Yahoo Finance

Tue, 08 Jul 2025
SRX Health Completes $7.3 Million Financing Led by Insiders - GlobeNewswire

Fri, 13 Jun 2025
SRx Health Solutions Announces New Leadership Team - TipRanks

Wed, 11 Jun 2025
SRx Health Solutions Announces Management and Board Changes - GlobeNewswire

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Outperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NYSE
Sector: Healthcare
Industry: Drug Manufacturers - General
Shares Out	0 (M)
Shares Float	0 (M)
Held by Insiders	0 (%)
Held by Institutions	0 (%)
Shares Short	0 (K)
Shares Short P.Month	0 (K)

EPS	0
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	0 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	0
PEG Ratio	0
Price to Book value	0
Price to Sales	0
Price to Cash Flow	0

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.